Wildcat Capital Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-492,000
| Closed | -$600K | – | 29 |
|
|
2019
Q3 | $600K | Sell |
492,000
-64,453
| -12% | -$78.6K | 0.25% | 23 |
|
|
2019
Q2 | $568K | Hold |
556,453
| – | – | 0.25% | 21 |
|
|
2019
Q1 | $879K | Hold |
556,453
| – | – | 0.52% | 16 |
|
|
2018
Q4 | $645K | Hold |
556,453
| – | – | 0.42% | 16 |
|
|
2018
Q3 | $2.06M | Hold |
556,453
| – | – | 1.59% | 10 |
|
|
2018
Q2 | $1.7M | Hold |
556,453
| – | – | 1.3% | 11 |
|
|
2018
Q1 | $2.17M | Sell |
556,453
-252,521
| -31% | -$982K | 1.79% | 11 |
|
|
2017
Q4 | $3.63M | Sell |
808,974
-2,582,565
| -76% | -$11.6M | 3.86% | 6 |
|
|
2017
Q3 | $18.6M | Hold |
3,391,539
| – | – | 3.33% | 3 |
|
|
2017
Q2 | $25.7M | Sell |
3,391,539
-1,093,956
| -24% | -$8.3M | 6.84% | 3 |
|
|
2017
Q1 | $15.9M | Hold |
4,485,495
| – | – | 5.04% | 3 |
|
|
2016
Q4 | $25.7M | Hold |
4,485,495
| – | – | 11.8% | 3 |
|
|
2016
Q3 | $34.9M | Sell |
4,485,495
-10,000
| -0.2% | -$77.8K | 10.52% | 3 |
|
|
2016
Q2 | $28M | Hold |
4,495,495
| – | – | 10.54% | 3 |
|
|
2016
Q1 | $37M | Hold |
4,495,495
| – | – | 12.85% | 3 |
|
|
2015
Q4 | $77.9M | Hold |
4,495,495
| – | – | 21.98% | 2 |
|
|
2015
Q3 | $51.5M | Buy |
+4,495,495
| New | +$51.5M | 19.23% | 2 |
|